-
Mayzent FDA-Approved for Relapsing Types of MS
The FDA approved Novartis’ Mayzent (siponimod) tablets for adults with relapsing MS forms, including active secondary progressive disease. Learn more about this therapy and its potential for treating MS here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.